The Harvard Department of Stem Cell and Regenerative Biology (HSCRB) is a joint department of Harvard University’s Faculty of Medicine and Faculty of Arts and Sciences, the first such department in the University’s history. The department is led by a chair and co-chair, who determine strategy and set priorities, consulting closely with HSCRB faculty. They are supported in their leadership roles by the Dean of Science and the Dean of the Faculty of Medicine. An executive director ensures the smooth running of the department.
Department Chair and Co-Chair
The Chair of HSCRB is Paola Arlotta, Golub Family Professor of Stem Cell and Regenerative Biology and a Harvard College Professor, who took on this strategic leadership role in September 2018. She said:
“This is a special time for our field. We have learned so much about what stem cells can do, and are poised to apply it to making new tissues and organs. When you combine all these new possibilities for understanding human diseases with the unique perspective students bring, that’s when we’ll start to see real transformation.
“The diversity of disciplines among our faculty is truly unique, and continually pushes us to look at problems from many perspectives. We all share a common goal of obtaining a deeper understanding of how cells, tissues and organs are made, and applying that new knowledge to treat diseases.”
The diversity of disciplines among our faculty is truly unique, and continually pushes us to look at problems from many perspectives.
The department is co-chaired by Amy Wagers, the Forst Family Professor of Stem Cell and Regenerative Biology and a Harvard College Professor. In her role, Wagers focuses on maximizing the impact of cross-school interactions. She said:
“We have the world’s greatest, largest, most advanced roster of researchers all within a four-mile radius of our department, and a culture of exploration that allows us to go easily between immunology and stem cell biology or developmental biology and regenerative medicine. It is an honor to have this opportunity to strengthen our collaborations across schools and throughout the Boston biomedical community.”
We have the world’s greatest, largest, most advanced roster of researchers all within a four-mile radius of our department.
HSCRB administration and communications teams are led by Kristen Elwell and Bill Thompson, Interim Executive Co-Directors. They have oversight of all aspects of operations, including research compliance, grants, finance, facilities, education, and communications.